Relative contribution of individual oxidized components in ox-LDL to inhibition on endothelium-dependent relaxation in rat aorta

Nutr Metab Cardiovasc Dis. 2011 Mar;21(3):157-64. doi: 10.1016/j.numecd.2008.12.017. Epub 2009 Dec 14.

Abstract

Background and aim: Oxidized low-density lipoprotein (ox-LDL) causes atherosclerosis and endothelial dysfunction. No study up to the present date has examined the relative contribution of all the oxidized components in ox-LDL to inhibition on vascular function. Our aim was to investigate the effects of individual oxidized components at concentrations similar to those in ox-LDL on the impairment of endothelium-dependent relaxation in rat aorta.

Methods and results: Rat thoracic aorta was pre-treated with lysophosphatidylcholine (LPC), cholesterol oxidized products (COPs), oxidized linoleic acid (ox-18:2) and oxidized linolenic acid (ox-18:3) at concentrations similar to those in human ox-LDL. Ox-LDL as a whole caused 61% inhibition while LPC, COPs and ox-18:2 at concentrations similar to those in ox-LDL caused 12%, 24% and 19% inhibition, respectively, on endothelium-dependent relaxation, suggesting that COPs produced the most adverse effect followed by ox-18:2 and LPC in an additional way. Three COPs including 7-ketocholesterol, 7α-hydroxycholesterol and 7β-hydroxycholesterol showed inhibition on endothelium-dependent relaxation with E(max) being reduced to 79-87% compared with the control E(max) (95%). At Western blot analysis phosphorylation of eNOS at Ser1177 site and total eNOS were not altered by ox-LDL treatment, indicating that ox-LDL did not affect nitric oxide (NO) synthesis capacity. Ox-LDL might react directly with NO and lower NO bioavailability.

Conclusion: The present study demonstrated the relative contribution of individual oxidized components in ox-LDL in the inhibition of endothelium-dependent relaxation in rat aorta. This inhibitory effect could be caused by the reduction of NO bioactivity.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aorta, Thoracic* / drug effects
  • Aorta, Thoracic* / metabolism
  • Cholesterol / chemistry
  • Cholesterol / metabolism
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / metabolism*
  • Humans
  • Hydroxycholesterols / analysis
  • Hydroxycholesterols / pharmacology
  • In Vitro Techniques
  • Isomerism
  • Ketocholesterols / analysis
  • Ketocholesterols / pharmacology
  • Linoleic Acid / chemistry
  • Linoleic Acid / metabolism
  • Lipoproteins, LDL / chemistry
  • Lipoproteins, LDL / metabolism*
  • Lysophosphatidylcholines / metabolism
  • Male
  • Nitric Oxide Synthase Type III / metabolism
  • Osmolar Concentration
  • Oxidation-Reduction
  • Phosphorylation
  • Rats
  • Rats, Sprague-Dawley
  • Vasodilation* / drug effects
  • alpha-Linolenic Acid / chemistry
  • alpha-Linolenic Acid / metabolism

Substances

  • Hydroxycholesterols
  • Ketocholesterols
  • Lipoproteins, LDL
  • Lysophosphatidylcholines
  • oxidized low density lipoprotein
  • alpha-Linolenic Acid
  • cholest-5-en-3 beta,7 alpha-diol
  • Cholesterol
  • Linoleic Acid
  • Nitric Oxide Synthase Type III
  • Nos3 protein, rat
  • 7-ketocholesterol